BOEHRINGER INGELHEIM INDIA PARTNERS WITH VVAAN LIFESCIENCES TO BROADEN PET PORTFOLIO REACH

Boehringer Ingelheim India has announced a strategic distribution partnership with Vvaan Lifesciences Private Limited to expand the reach of its pet parasiticide portfolio across India.

- 

This collaboration is a key initiative under Boehringer Ingelheim India's Animal Health Accelerated Growth Plan (AGP) and represents a significant milestone in the company’s efforts to enhance customer value and access in the growing animal health sector.

India’s pet healthcare market is estimated to be worth around EUR 115 million. According to Boehringer Ingelheim India’s internal analysis, metropolitan and Tier 1 cities account for approximately 60% of the total market revenue, while Tier 2 and smaller cities contribute the remaining 40%. Recognizing the untapped potential in these underserved areas, this partnership seeks to leverage Vvaan Lifesciences’ expertise and strong presence in Tier 2 cities to extend the reach of Boehringer Ingelheim’s pet portfolio.